Fisher Asset Management LLC Sells 3,007 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Fisher Asset Management LLC reduced its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 0.9% in the 4th quarter, HoldingsChannel reports. The firm owned 314,386 shares of the company’s stock after selling 3,007 shares during the quarter. Fisher Asset Management LLC’s holdings in Prestige Consumer Healthcare were worth $24,550,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Kestra Investment Management LLC bought a new stake in Prestige Consumer Healthcare in the fourth quarter valued at $27,000. Huntington National Bank increased its stake in Prestige Consumer Healthcare by 39.9% in the third quarter. Huntington National Bank now owns 635 shares of the company’s stock valued at $46,000 after purchasing an additional 181 shares in the last quarter. International Assets Investment Management LLC increased its stake in Prestige Consumer Healthcare by 7,112.5% in the third quarter. International Assets Investment Management LLC now owns 1,154 shares of the company’s stock valued at $83,000 after purchasing an additional 1,138 shares in the last quarter. Covestor Ltd increased its stake in Prestige Consumer Healthcare by 95.6% in the third quarter. Covestor Ltd now owns 1,338 shares of the company’s stock valued at $96,000 after purchasing an additional 654 shares in the last quarter. Finally, GAMMA Investing LLC increased its stake in Prestige Consumer Healthcare by 18.9% in the fourth quarter. GAMMA Investing LLC now owns 1,383 shares of the company’s stock valued at $108,000 after purchasing an additional 220 shares in the last quarter. 99.95% of the stock is owned by institutional investors.

Analysts Set New Price Targets

PBH has been the subject of several recent research reports. Oppenheimer boosted their target price on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an “outperform” rating in a research report on Thursday, February 13th. Canaccord Genuity Group boosted their target price on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. Sidoti downgraded shares of Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 target price for the company. in a research report on Monday, December 9th. StockNews.com raised shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research report on Friday, January 24th. Finally, DA Davidson boosted their target price on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $92.60.

Prestige Consumer Healthcare Stock Up 0.7 %

Prestige Consumer Healthcare stock opened at $85.34 on Tuesday. Prestige Consumer Healthcare Inc. has a fifty-two week low of $62.35 and a fifty-two week high of $88.36. The stock has a market cap of $4.23 billion, a PE ratio of 19.99, a price-to-earnings-growth ratio of 2.69 and a beta of 0.50. The firm’s 50-day simple moving average is $80.18 and its 200 day simple moving average is $77.40. The company has a debt-to-equity ratio of 0.56, a quick ratio of 2.20 and a current ratio of 3.68.

Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings results on Thursday, February 6th. The company reported $1.22 earnings per share for the quarter, topping the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. Research analysts predict that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.